Unpublished trial results are “ethical failure”
Michael Cook | 09 November 2013 |
Nearly 300,000 people who participated in clinical trials have been exposed to harm without any personal or social benefit, according to research published in the BMJ.
FIGHTING EXPLOITATION 2: Indian clinical trial consents to be videotaped
Michael Cook | 26 October 2013 |
The Indian Supreme Court has ordered the central government to ensure that the informed consent of any patients in clinical trial be videotaped.
Another unethical study – this time in NY’s Bowery
Michael Cook | 19 October 2013 |
In the 1950s an oncologist recruited homeless men for a study of prostate cancer.
GlaxoSmithKlein slammed for unethical drug trials in China
Xavier Symons | 27 July 2013 |
British pharmaceutical company GlaxoSmithKlein has been exposed for conducting unethical drug trials in its Shanghai office.
Does the development of IVF have a murky past?
Michael Cook | 27 July 2013 |
Was Patrick Steptoe, one of the famed creators of IVF, sensitive to research ethics?
First drug to help Down syndrome people now being tested
Michael Cook | 20 April 2013 |
The first drug to help people with Down syndrome overcome cognitive deficits is being tested on humans.
Doctors failed to disclose risks in study of baby blindness, says US agency
Michael Cook | 13 April 2013 |
Scientists at a number of top American universities failed to inform parents of the grave risks of enrolling in a clinical trial on blindness in premature babies, says the federal agency overseeing the welfare of people in research projects.
The true “immorality” of test-tube babies
Michael Cook | 07 February 2013 |
However, a journalist for the American financial magazine Forbes has once again raised the issue of IVF ethics. Its "original sin", says Peter Ubel, was lack of informed consent in the birth of Louise Brown, the first "test-tube baby".
Thalidomide apology derided as too little, too late
Michael Cook | 14 September 2012 |
Fifty years after the calamitous release of the sedative Thalidomide by the German company Gruenenthal, the company has finally issued an apology.
India wants more compensation for victims of clinical trials
Michael Cook | 24 August 2012 |
New rules in India will force pharmaceutical companies to pay higher compensation if patients in clinical trials die or are injured.
Startling admissions in IVF journal
Michael Cook | 04 August 2012 |
Some IVF patients are being offered risky, unsafe techniques which have not been developed ethically and which offer dubious benefits, according to an extraordinary article in the journal Reproductive BioMedicine Online (RBO).
Justice needed for injured research subjects, says bioethicist
Michael Cook | 06 July 2012 |
University of Minnesota bioethicist Carl Elliott has composed a handy primer on how to exploit a research subject in his blog: “Step 1: Design a risky, deceptive or scientifically worthless study. Step 2: Injure subjects. Step 3: Bankrupt the injured subjects by forcing them to pay for their medical care.”
Panel gives US govt funded clinical research clean bill of health
Michael Cook | 17 December 2011 |
Current rules and regulations provide adequate safeguards to mitigate risk in clinical trial, says the Presidential Commission for the Study of Bioethical Issues. After a survey of federally-sponsored research involving human volunteers after a scandal over highly unethical treatment of Guatemalan patients in the late 1940s by doctors in the Public Health Service, Commission basically gave American research a clean bill of health.
US mothers participate in clinical trials to make ends meet
Jared Yee | 25 November 2011 |
More cash-strapped mums are signing up for clinical trials.
Questions over clinical trials in India
Jared Yee | 24 November 2011 |
Western pharmaceutical companies have pinpointed India as a prime candidate for outsourcing clinical trials, due to its population and lax regulations, which help slash research costs.
Panel urges ethics study of testing anthrax vaccine on children
Jared Yee | 03 November 2011 |
Informed consent and the possible threat of terrorist attack have clashed in a debate over whether an anthrax vaccine should be tested on children.
Are we morally obliged to participate in research?
Michael Cook | 22 October 2011 |
Bioethics debates are often robust, but it’s not every day that they make a reader sick. This was the reaction of Professor Bill Gleason, of the University of Minnesota Medical School, a columnist for the Chronicle of Higher Education. He had just attended a seminar at his university, “Do people have a moral obligation to participate in research?”. The contrarian views of Rosamund Rhodes, of Mt. Sinai School of Medicine, in New York, were so unsettling that he needed three beers to come back to earth.
Interview: John D. Arras on the Guatemala syphilis study
Michael Cook | 26 September 2011 |
Embryonic stem cell trial to begin in UK
Michael Cook | 23 September 2011 |
Guatemalans were victims of US syphilis study in 1940s
29 May 2011 |
The horrendous syphilis experiment conducted by American doctors on Guatemalan prisoners and soldiers is finally getting some news coverage.